Peter B. van den Boezem
Papers
8
Total Citations
131
H-Index
5
About
Peter B. van den Boezem is a leading surgical researcher whose work centers on advancing minimally invasive techniques in hepatopancreatobiliary (HPB) surgery, with a particular focus on pancreatic and liver resections. His major contributions include landmark randomized trials such as the LEOPARD trial, which demonstrated that minimally invasive distal pancreatectomy reduces time to functional recovery compared to open surgery, and the LAEBOT 3D2D trial, which rigorously evaluated the added value of 3D-vision in robotic pancreatoduodenectomy anastomoses. His pooled analyses comparing robotic, 3D-laparoscopic, and 2D-laparoscopic performance in biotissue models have provided critical evidence on surgical precision. With over 130 citations across his most-cited works, van den Boezem has shaped the debate on cost-effectiveness, quality of life, and conversion risks in minimally invasive surgery. His nationwide propensity-matched analyses of robotic versus laparoscopic liver resections have clarified outcomes and risk factors for conversion, influencing clinical guidelines. Notably, his work on extended left pancreatectomy and a Cochrane protocol for minimally invasive versus open pancreatoduodenectomy underscore his commitment to evidence-based surgical innovation. Van den Boezem’s research is essential reading for surgeons and trainees navigating the evolving landscape of robotic and laparoscopic HPB surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6Robot-assisted and Laparoscopic Extended Left Pancreatectomy3 citations · 2025
- 7
- 8